Advertisement

PharmacoEconomics & Outcomes News

, Volume 399, Issue 1, pp 5–5 | Cite as

Basiliximab confers significant clinical benefit for marginal cost

Clinical study
  • 8 Downloads

Keywords

Renal Transplantation Marginal Cost Acute Rejection Rejection Episode Basiliximab 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2003

Personalised recommendations